CD274 and large cell neuroendocrine carcinoma: PD-L1 was evaluated in relation to the LCNEC subgroups revealing that tumor PD-L1 ≥ 1% is expressed in 16% of metastatic LCNEC and PD-L1 expression was not significantly different between the molecular subgroups of LCNEC (45).